Live Breaking News & Updates on Mayne pharma

Stay informed with the latest breaking news from Mayne pharma on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Mayne pharma and stay connected to the pulse of your community

Lupin gets target hike from Nomura to Rs 1,949 on growth potential in US products

Nomura suggests that the launch of US products and stringent cost control measures could exceed current earnings estimates. Additionally, Lupin has potential limited competition opportunities in FY25 with products like gOracea, gMyrbetriq, and gSlynd, pending a favorable verdict.

Mayne-pharma , Brokerage-nomura , Markets-news , Quity-markets , Uzzing-stocks , Upin ,

Analysts' Weekly Ratings Changes for TherapeuticsMD (TXMD)

Analysts' Weekly Ratings Changes for TherapeuticsMD (TXMD)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Mayne-pharma , News-ratings-for-therapeuticsmd-inc-daily , Geode-capital-management , Capital-management , Therapeuticsmd-inc , Blackrock-inc , Street-corp ,

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)

StockNews.com assumed coverage on shares of TherapeuticsMD (NASDAQ:TXMD – Free Report) in a research report sent to investors on Monday. The firm issued a hold rating on the stock. TherapeuticsMD Trading Down 0.9 % TherapeuticsMD stock opened at $2.23 on Monday. The business’s 50-day simple moving average is $2.31 and its two-hundred day simple moving […]

United-states , Mayne-pharma , Therapeuticsmd-company-profile , Therapeuticsmd-inc , Principal-financial-group-inc , Charles-schwab-investment-management-inc , Free-report , Street-corp , Financial-group , Schwab-investment-management , Rhumbline-advisers , Get-free-report

TherapeuticsMD Announces Full Year 2023 Financial Results

• Evaluation of strategic alternatives continues

...

Mayne-pharma , Marland-walker , Exchange-commission , Service-revenues , Nasdaq , Therapeuticsmd-inc , Chief-executive-officer , Mayne-license-agreement , Mayne-license , Operating-expenses , Annual-report , Quarterly-reports

TherapeuticsMD Announces Full Year 2023 Financial Results

TherapeuticsMD Announces Full Year 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Marland-walker , Lisam-wilson , Mayne-pharma , Site-communications-inc , Exchange-commission , Nasdaq , Therapeuticsmd-inc , Service-revenues , Chief-executive-officer , Mayne-license-agreement , Mayne-license , Operating-expenses

TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com

TherapeuticsMD (NASDAQ:TXMD) Research Coverage Started at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Mayne-pharma , Therapeuticsmd-inc , Jpmorgan-chase-co , Principal-financial-group-inc , Renaissance-technologies , Therapeuticsmd-company-profile , Get-free-report , Financial-group , State-street-corp , Street-corp ,

TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com

TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Blackrock , Nova-scotia , Canada , United-states , Mayne-pharma , Charles-schwab-investment-management-inc , Millennium-management , Blackrock-inc , Royal-bank , Geode-capital-management , Therapeuticsmd-inc , Get-free-report

Form 10-K Evofem Biosciences, Inc. For: Dec 31

Form 10-K Evofem Biosciences, Inc. For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Delaware , United-states , San-diego , California , Walnut-creek , Japan , Nigeria , Ukraine , Spain , Miami , Florida , Mississippi

Recent Investment Analysts' Ratings Updates for TherapeuticsMD (TXMD)

TherapeuticsMD (NASDAQ: TXMD) has recently received a number of price target changes and ratings updates: 2/25/2024 – TherapeuticsMD is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 2/19/2024 – TherapeuticsMD is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 2/13/2024 – TherapeuticsMD is […]

United-states , Canada , Marland-walker , Mayne-pharma , News-ratings-for-therapeuticsmd-inc-daily , Goldman-sachs-group-inc , Royal-bank , Renaissance-technologies , Therapeuticsmd-inc , Street-corp , Sachs-group , Clearline-capital

Global pharmaceutical manufacturer arriving in South Australia

Global pharmaceutical manufacturer arriving in South Australia
manmonthly.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from manmonthly.com.au Daily Mail and Mail on Sunday newspapers.

Salisbury , Mashonaland-east , Zimbabwe , United-kingdom , Adelaide-oval , South-australia , Australia , Mayne-pharma , United-kingdom-noumed-life-sciences , Government-modern-manufacturing-initiative , Noumed-life-sciences , Federal-government